Safety alertSource: FDA Drug Enforcement Reports
Class I recall: Baxter Healthcare Corporation: Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporat
Baxter Healthcare Corporation issued a Class I recall for Dextrose Injection, USP, 70%, 2000 mL bags (NDC 00338-0719-06). The recall states the product contains particulate matter identified as stainless steel particles in the solution.
Most relevant for: Clinicians and facilities that administer or stock parenteral dextrose solutions, such as those managing patients on IV nutrition or fluid therapy.
Read the original at FDA Drug Enforcement ReportsSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
Internal MedicineFamily MedicinePediatricsCardiologyOncologyEndocrinologyOtolaryngology (ENT)SurgeryGynecology & ObstetricsOrthopedicsOphthalmologyDermatologyNeurologyAllergy & ImmunologyEmergency MedicinePathologyPsychiatryPlastic SurgeryNuclear MedicineRadiologyPublic HealthPreventive MedicineToxicologyClinical PharmacologyIntensive Care MedicinePulmonologyRheumatologyGastroenterologyInfectious DiseasesNeonatologyVascular SurgeryAnesthesiologyPain ManagementPediatric Emergency Medicine
More internal medicine updates
- Long-acting injectable noninferior to oral HIV therapy in adherence trialOct 15, 2026
- Ponatinib-Blinatumomab Beats Imatinib-Chemotherapy in Ph-Positive ALL TrialOct 15, 2026
- Isoflurane sedation does not lower mortality in hypoxemic respiratory failureOct 14, 2026
- Trial finds higher mortality with intermittent vs continuous renal-replacement therapyOct 14, 2026
- No Overall Rise in Birth Defects With Early Benzodiazepine UseOct 13, 2026